Related Experiment Video
Updated: Nov 29, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Adherence with an Acute Agitation Algorithm and Subsequent Restraint Use
Meredith Jenkins1, Michelle Caruso Barrett2, Theresa Frey3,4
1Division of Pharmacy, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH, 45229, USA. meredith.jenkins@cchmc.org.
Insights
Standardized pharmacological treatment for acute agitation in pediatric emergency departments did not reduce physical restraint use. Medications were safe, but adherence to guidelines did not significantly impact restraint rates.
Area of Science:
- Pediatric Emergency Medicine
- Pharmacology
- Patient Safety
Background:
- Acute agitation in pediatric patients often necessitates interventions like physical restraints.
- Pharmacological interventions are increasingly used to manage acute agitation.
- Standardized treatment protocols aim to optimize care and reduce adverse events.
Purpose of the Study:
- To evaluate if adherence to standardized pharmacological recommendations decreases physical restraint use in acutely agitated pediatric patients.
- To identify predictors of physical restraint use.
- To describe adverse events associated with pharmacological treatment.
Main Methods:
- Retrospective chart review of pediatric emergency department visits from September 1, 2016, to August 31, 2017.
- Inclusion criteria: pediatric patients treated for acute agitation with pharmacologic management or physical restraint.
- Comparison of physical restraint rates between patients treated per recommendations and those not.
Main Results:
- No significant difference in physical restraint use was observed between adherence to and non-adherence to standardized recommendations (P=0.16).
- Presentation during day shift, compared to evening shift, increased the odds of physical restraint use (OR 2.03; 95% CI 1.18, 3.50).
- Nine adverse events possibly related to medications were reported, none of significant clinical concern.
Conclusions:
- Standardized pharmacological treatment recommendations were not associated with a decrease in physical restraint use for agitated pediatric patients.
- Pharmacological strategies were generally safe and well-tolerated in this population.
- Further research may be needed to identify effective strategies for reducing physical restraint use in pediatric agitation.
Abstract:
Timely use of pharmacological interventions to treat acute agitation has the potential to decrease physical restraint use. The aim of this study is to determine if adherence to standardized pharmacological recommendations for the treatment of acutely agitated pediatric patients decreases physical restraint use. Additionally, this study aims to identify predictors of physical restraint use and describe treatment related adverse events. This is a retrospective chart review of patient visits between September 1, 2016 and August 31, 2017. Patient visits were included if the patient presented to the pediatric emergency department, met ICD-10 codes, and received pharmacologic management or physical restraint to treat acute agitation. The differences in rate of physical restraint was assessed between patients treated according to the standardized pharmacological recommendations and patients who were not. 447 patients were included with a mean age of 13 years. No significant difference in physical restraint use was found when standardized pharmacological recommendations were followed compared to when they were not (P = 0.16). Only presentation on day shift when compared to evening shift resulted in increased odds of being restrained (OR 2.03; 95% CI 1.18, 3.50). Nine adverse events possibly related to medications were identified with none considered to be of significant clinical concern. Standardized pharmacological treatment recommendations was not associated with a decrease in physical restraint use for agitated patients presenting to the pediatric emergency department. The pharmacologic strategies utilized were generally safe and well tolerated in this patient population.
More Related Videos
06:51Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
Published on: July 29, 2016
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Drug Therapy
Antianxiety Medications
Aggression